In the pharmaceutical industry, the quality of raw materials and intermediates is paramount. For a compound like 4-Phenylbutan-1-ol (CAS: 3360-41-6), its role as a key intermediate in the synthesis of vital medications such as Salmeterol places an exceptionally high demand on its purity and specifications. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to meeting these exacting standards.

The specifications for 4-Phenylbutan-1-ol typically include a minimum assay value, often requiring ≥98.0% purity. This high purity level is essential because even trace impurities can have significant downstream effects. Impurities might interfere with reaction yields, introduce unwanted byproducts that are difficult to remove, or, most critically, compromise the safety and efficacy of the final drug product. Therefore, robust quality control and analytical testing are integral to the production of this intermediate.

Beyond the main component assay, the impurity profile of 4-Phenylbutan-1-ol is also closely monitored. Identifying and quantifying residual starting materials, synthesis byproducts, or degradation products is a crucial aspect of quality assurance. Understanding these impurities allows manufacturers to implement effective purification strategies and ensures that the intermediate meets pharmacopoeial standards or client-specific requirements.

NINGBO INNO PHARMCHEM CO.,LTD. employs rigorous quality management systems to ensure that every batch of 4-Phenylbutan-1-ol released meets the highest standards. This includes comprehensive analytical testing using validated methods to confirm purity, identify potential impurities, and verify physical characteristics. Our commitment to quality assurance underpins our role as a trusted supplier to the pharmaceutical sector.

The consistent adherence to these strict specifications for 4-Phenylbutan-1-ol is not merely a matter of compliance; it is a fundamental requirement for ensuring the reliability of the pharmaceutical supply chain. By providing a high-quality, well-characterized intermediate, we empower our clients to manufacture safe and effective medications that ultimately benefit patient health.